LENSAR Inc — Quarterly Financial Statistics (NASDAQ:LNSR)

Financials

Cash from operating activities -3.15 M-3.66 M6.94 M5 M3.51 M 11.79 M Cash from investing activities 905 K-1.99 M531 K6.43 M-4 M 969 K Cash from financing activities 93 K-16 K9.69 M93 K0 9.77 M Free cash flow -3.17 M-3.66 M6.93 M4.92 M3.51 M 11.71 M

新闻

Закрытие сделки LENSAR-Alcon перенесено на первую половину 2026 года

LENSAR-Alcon deal closing pushed to first half of 2026

Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)

LENSAR: доходы, прибыль оказались ниже прогнозов в Q3

LENSAR earnings missed by $0.26, revenue fell short of estimates

LENSAR earnings missed by $0.08, revenue fell short of estimates

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)

Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)

Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)

LENSAR stock surges 23.7% as Q4 revenue beats estimates